United States
Rep Login: blueWire
Medtronic Cardiac Diagnostics & Monitoring – For Healthcare Professionals
Cardiac Diagnostics & Monitoring

For Healthcare Professionals

Cryptogenic Stroke Pathway Guide Header Image 1

WHAT IS A CRYPTOGENIC STROKE PATHWAY?

A Cryptogenic Stroke Pathway is a consistent approach to a follow-up plan and transition of care for patients with a stroke of unknown source. This implementation guide is intended to extend your acute stroke protocol to include a monitoring plan for cryptogenic stroke patients. It includes monitoring for AF with the best monitoring mechanisms available to optimize outcomes.

Why Establish a Cryptogenic Stroke Pathway?

After initial stroke discharge, many patients are not receiving any additional cardiac monitoring. Establishing a monitoring pathway to detect and treat AF can significantly reduce a patient’s risk for another stroke. The ability to identify AF in patients with cryptogenic stroke has profound implications for long-term medical management.

Stroke detection treatment matters stats

Many cryptogenic stroke patients are lost to follow-up. Pathways for transition of care and follow-up help to ensure these patients receive better care.


A Cryptogenic Stroke Pathway allows all healthcare professionals involved in the continuum to ensure a standard of care. Through this pathway, hospitals can:
  • Provide underserved patient population a better risk reduction strategy to prevent a secondary stroke
  • Establish cross-functional healthcare professional relationships to ensure integrated care delivery
  • Ensure multidisciplinary stroke care involving both neurological and cardiovascular care
  • Enhance hospital reputation in providing exemplary stroke care

 

Next: Planning the Cryptogenic Stroke Pathway

References
  1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. September 1987;147(9):1561-1564.
  2. Lin HJ, Kelly-Hayes M, Beiser AS, et al. Stroke Severity in Atrial Fibrillation: The Framingham Study. Stroke. 1996;27:1760-1764.
  3. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation. August 1991;84(2):527-539.